The letter encourages federal agencies to consider the new United Kingdom roadmap as a model for balanced, collaborative, and evidence-based progress

November 25, 2025

Americans for Medical Progress (AMP) transmitted a letter to National Institutes of Health (NIH) Director Dr. Jay Bhattacharya, Dr. Nicole Kleinstreuer, and Food & Drug Administration (FDA) Commissioner Dr. Marty Makary urging the development of a coordinated national strategy on New Approach Methodologies (NAMs). The letter points to the United Kingdom’s newly released national roadmap on replacing animals in science as a constructive model for balanced, realistic, and evidence-driven progress.

AMP emphasizes that the UK framework stands out for its collaborative approach and its acknowledgment that, while alternatives are rapidly advancing, animal studies remain necessary where methods are not yet validated or safe.

The letter calls for a U.S. strategy that strengthens interagency coordination, aligns communication and regulatory expectations, and supports integrative research approaches rather than exclusionary policies.

AMP welcomes the opportunity to partner with federal agency leadership and scientific stakeholders to ensure the responsible advancement of non-animal innovation while protecting scientific integrity and public trust.

A PDF copy of AMP’s letter is available here.